BBIO
BBIO
NASDAQ · Biotechnology

Bridgebio Pharma Inc

Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks
$68.53
-1.07 (-1.54%)
Analyst Consensus
Strong Buy
28
Analysts
High
Coverage
Buy 27 96%
Hold 1 4%
Sell 0 0%
Price Target
Analyst Price Target +177.3% upside
Low Target $141.92
Average Target $190.06
High Target $243.96
Current Price $68.53
Current
$68.53
Target
$190.06
$141.92 $190.06 avg $243.96
Scenario Analysis
Bear Case
$141.92
107.1%
Low target
Base Case
$190.06
+177.3%
Avg target
Bull Case
$243.96
+256.0%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$84.94
-19.3% from high
52-Week Low
$28.33
+141.9% from low
50-Day SMA
$75.38
-9.1% vs SMA
200-Day SMA
$56.39
+21.5% vs SMA
RSI (14)
38.4
Neutral
Target vs 52W High
$190.06
+123.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 39 69% $257.58 +24.6%
AMGN
Amgen Inc
 Hold 42 50% $190.87 -46.2%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +161.7%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 -2.3%
REGN
Regeneron Pharmaceuticals
 Strong Buy 36 75% $76.80 -89.8%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 78% $102.31 -68.6%
INSM
Insmed Inc
 Strong Buy 26 92% $143.40 -3.3%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -27.6%